Braham Shroot, Ph.D. has been appointed chief scientific officer of Barrier Therapeutics. In this role, he will manage the company’s R&D activities, reporting to Geert Cauwenbergh, Ph.D., chief executive officer. “Dr. Shroot’s extensive scientific background, as well as his established record in dermatological product development, makes him an ideal leader for Barrier’s research and development organization, where we have a broad pipeline of product candidates fo...